Anavex Life Sciences (AVXL) Return on Assets (2017 - 2025)

Anavex Life Sciences (AVXL) has 9 years of Return on Assets data on file, last reported at 3.58% in Q4 2025.

• For the quarter ending Q4 2025, Return on Assets fell 357.0% year-over-year to 3.58%; the trailing twelve-month figure through Dec 2025 stood at 3.58% (down 357.0% YoY), and the FY2025 full-year result was 3.32%, down 332.0% from the prior year.
• Return on Assets advanced to 3.58% in Q4 2025, from 3.87% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.0% in Q3 2021 to a low of 3.87% in Q3 2025.
• A 5-year average of 0.38% and a median of 0.0% in 2024 frame the typical range for Return on Assets.
• Across the five-year window, Return on Assets grew 1 bps in 2021 and tumbled 387 bps in 2025, its largest moves.
• Tracing AVXL's Return on Assets over 5 years: stood at 0.0% in 2021, then declined by 30 bps to 0.0% in 2022, then advanced by 14 bps to 0.0% in 2023, then slumped by 216 bps to 0.01% in 2024, then sank by 39554 bps to 3.58% in 2025.
• Business Quant data shows AVXL's Return on Assets at 3.58% in Q4 2025, 3.87% in Q3 2025, and 0.02% in Q2 2025.